Prevnar 20 Pediatric Senior Manager - HCP

New York, USA (Hybrid)

$124K/yr – $207K/yrSenior LevelFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Drive Prevnar 20 HCP strategy and tactical execution in a Senior Marketing Manager role, leading cross-functional digital engagement and competitive differentiation for Prevnar 20 Pediatric.

  • Lead the Prevnar 20 HCP strategy and tactical plan across functions.
  • Must-have: 6+ years in pharma/healthcare marketing with MS/MPH or BA+6.
  • Standout: Experience shaping digital engagement and content optimization.

Job Description

Responsibilities

  • HCP Strategy & Tactics: In collaboration with the HCP Directors, own the development and execution of the Prevnar 20 HCP strategy and tactical plan.
  • Drive the pull through of HCP tactics for Prevnar 20 Pediatric such as communication of scientific information and emphasizing the value of Prevnar 20 vs. competition.
  • Develop, deliver, and measure marketing solutions that differentiate Prevnar 20 Pediatric with HCPs through innovative CFC delivered digital engagement. As part of execution the Sr. Mgr. will assess digital metrics, insights and make recommendations for content and channel optimization.
  • Develop effective resources to help transition customers from competition to Prevnar 20.
  • Expand vaccine confidence efforts with HCPs to help foster vaccine initiation and adherence.
  • Engage with sales and account management leads to solicit insights, provide solutions, and drive utilization of materials, and ensure programs and resources are of value to and empower customer facing colleagues.
  • Develop training resources for use with CFCs and ensure they are appropriately prepared to drive business and are empowered to defend against competition.
  • Lead/assist with other critical responsibilities/business planning deliverables as needed– e.g. leadership reports, presentations, brand metrics.

Requirements

  • Bachelor’s degree in related area – e.g., Marketing, Life Sciences, etc.
  • Minimum 1 year of experience with PhD/DrPH/ScD/PharmD; minimum of 5 years of experience with MS/MPH; minimum of 6 years of experience with a Bachelor’s degree.
  • Ability to work independently across stakeholders and demonstrates judgement of what needs to be escalated
  • Excellent communication and presentation skills (oral and written)
  • Robust analytical/planning skills and ability to multi-task under pressure
  • Self-starter, comfortable with ambiguity
  • Solid understanding of today’s U.S. pharmaceutical environment, incl. Regulatory, Legal and Compliance

Preferred

  • 3+ years experience in the U.S. pharmaceutical industry preferred
  • Previous marketing experience preferred
  • MBA, MPH or similar

Benefits

  • We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments.
  • Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution
  • paid vacation
  • holiday and personal days
  • paid caregiver/parental and medical leave
  • health benefits to include medical, prescription drug, dental and vision coverage
Pfizer logo

Pfizer

We’re celebrating over 175 years of daring scientific innovation—and we’re not done yet. Let’s outdo yesterday. Protect your health at PfizerForAll.com For additional information on our guidelines, please visit http://www.pfizer.com/community-guidelines

New York, New York, USA
102K employees (4,879 in marketing)

Traffic Signals

Monthly Visitors
2.3M
Monthly Google Ads Budget
$117.8K
Traffic Source Mix
Search
54.8%
Direct
34.7%
Referral
8%
Social
1.4%
Paid
1%

Headcount Trend

Current headcount: ~102.3K

Marketing Team

Marketing Team Size
4,125 (4% of company)
Median Career Experience
17.5 years
Median Tenure
6.4 years
Marketing Roles Posted (Last 30 Days)
3

Funding

Total Funding
$38B
Last Raise
$6B
Post IPO Debt, 4 months ago

Funding History

  • Nov 2025
    Post IPO Debt • $6B
  • Oct 2024
    Post IPO Equity • $1B
  • May 2023
    Post IPO Debt • $31B

Recent News